α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery
- PMID: 24355812
- PMCID: PMC3970812
- DOI: 10.1016/j.biocel.2013.12.006
α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery
Abstract
Hepatocytes are metabolically active cells of the liver that play an important role in the biosynthesis of proteins including α1-antitrypsin. Mutations in the α1-antitrypsin gene can lead to protein misfolding, polymerization/aggregation and retention of protein within the endoplasmic reticulum of hepatocytes. The intracellular accumulation of α1-antitrypsin aggregates can lead to liver disease and increased likelihood of developing hepatocellular carcinomas. Of note, only ~10% of individuals with α1-antitrypsin-deficiency develop severe liver disease suggesting that there are other genetic and/or environmental factors that determine disease outcome. The nematode, Caenorhabditis elegans, is a powerful genetic model organism to study molecular aspects of human disease. In this review, we discuss the functional similarities between the intestinal cells of C. elegans and human hepatocytes and how a C. elegans model of α1-antitrypsin-deficiency can be used as a tool for identifying genetic modifiers and small molecule drugs.
Keywords: C. elegans; Hepatocyte; Liver disease; Protein aggregation; α1-Antitrypsin deficiency.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency.Biol Chem. 2019 Nov 26;400(12):1603-1616. doi: 10.1515/hsz-2018-0391. Biol Chem. 2019. PMID: 31091192
-
Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.Pediatr Res. 2014 Jan;75(1-2):133-9. doi: 10.1038/pr.2013.190. Epub 2013 Nov 13. Pediatr Res. 2014. PMID: 24226634 Free PMC article. Review.
-
A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency.Hum Mol Genet. 2014 Oct 1;23(19):5123-32. doi: 10.1093/hmg/ddu236. Epub 2014 May 16. Hum Mol Genet. 2014. PMID: 24838285 Free PMC article.
-
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.PLoS One. 2014 Jan 31;9(1):e87260. doi: 10.1371/journal.pone.0087260. eCollection 2014. PLoS One. 2014. PMID: 24498058 Free PMC article.
-
Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.Int J Mol Sci. 2021 Nov 18;22(22):12467. doi: 10.3390/ijms222212467. Int J Mol Sci. 2021. PMID: 34830348 Free PMC article. Review.
Cited by
-
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells.J Lipid Res. 2024 Dec;65(12):100692. doi: 10.1016/j.jlr.2024.100692. Epub 2024 Nov 5. J Lipid Res. 2024. PMID: 39505261 Free PMC article.
-
Impact of drug solvents on C. elegans pharyngeal pumping.Toxicol Rep. 2021 Jun 17;8:1240-1247. doi: 10.1016/j.toxrep.2021.06.007. eCollection 2021. Toxicol Rep. 2021. PMID: 34195015 Free PMC article.
References
-
- Branicky R, Desjardins D, Liu JL, Hekimi S. Lipid transport and signaling in Caenorhabditis elegans. Dev Dyn. 2010;239:1365–1377. - PubMed
-
- Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A. 2000;97:1796–17801. - PMC - PubMed
-
- Carrell RW, Lomas DA. Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med. 2002;346:45–53. - PubMed
-
- de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002;122:1818–1829. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical